Literature DB >> 7712003

Receptors for endothelin-1 in asthmatic human peripheral lung.

P G Knott1, A C D'Aprile, P J Henry, D W Hay, R G Goldie.   

Abstract

[125I]-endothelin-1 ([125I]-ET-1) binding was assessed by autoradiography in peripheral airway smooth muscle and alveolar wall tissue in human non-asthmatic and asthmatic peripheral lung. Levels of specific binding to these structures were similar in both non-asthmatic and asthmatic lung. The use of the receptor subtype-selective ligands, BQ-123 (ETA) and sarafotoxin S6c (ETB), demonstrated the existence of both ETA and ETB sites in airway smooth muscle and in alveoli. In airway smooth muscle from both sources, the great majority of sites were of the ETB subtype. Quantitative analyses of asthmatic and non-asthmatic alveolar wall tissue demonstrated that 29-32% of specific [125I]-ET-1 binding was to ETA sites and 68-71% was to ETB sites. Thus, asthma was not associated with any significant alteration in the densities of ETA and ETB receptors in peripheral human lung.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7712003      PMCID: PMC1510163          DOI: 10.1111/j.1476-5381.1995.tb14895.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  Distribution of beta 1- and beta 2-adrenoceptors in mouse trachea and lung: a quantitative autoradiographic study.

Authors:  P J Henry; P J Rigby; R G Goldie
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

2.  Endothelin in human nasal mucosa.

Authors:  J Mullol; B A Chowdhury; M V White; K Ohkubo; R D Rieves; J Baraniuk; J N Hausfeld; J H Shelhamer; M A Kaliner
Journal:  Am J Respir Cell Mol Biol       Date:  1993-04       Impact factor: 6.914

Review 3.  Endothelin and the respiratory system.

Authors:  D W Hay; P J Henry; R G Goldie
Journal:  Trends Pharmacol Sci       Date:  1993-01       Impact factor: 14.819

4.  Increased endothelin-like immunoreactive material on bronchoalveolar lavage fluid from patients with bronchial asthma and patients with interstitial lung disease.

Authors:  M Sofia; M Mormile; S Faraone; M Alifano; S Zofra; L Romano; L Carratù
Journal:  Respiration       Date:  1993       Impact factor: 3.580

5.  Some statistical methods useful in circulation research.

Authors:  S Wallenstein; C L Zucker; J L Fleiss
Journal:  Circ Res       Date:  1980-07       Impact factor: 17.367

6.  Relationship between endothelin-1 binding site densities and constrictor activities in human and animal airway smooth muscle.

Authors:  P J Henry; P J Rigby; G J Self; J M Preuss; R G Goldie
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

7.  Endothelin immunoreactivity of airway epithelium in asthmatic patients.

Authors:  D R Springall; P H Howarth; H Counihan; R Djukanovic; S T Holgate; J M Polak
Journal:  Lancet       Date:  1991-03-23       Impact factor: 79.321

8.  Effect and distribution of intravenously injected 125I-endothelin-1 in rat kidney and lung examined by electron microscopic radioautography.

Authors:  S Furuya; S Naruse; T Nakayama; K Nokihara
Journal:  Anat Embryol (Berl)       Date:  1992

9.  Role of endothelin-1 in regulating proliferation of cultured rabbit airway smooth muscle cells.

Authors:  J P Noveral; S M Rosenberg; R A Anbar; N A Pawlowski; M M Grunstein
Journal:  Am J Physiol       Date:  1992-09
  9 in total
  11 in total

1.  Characterization of endothelin receptors in the peripheral lung tissues of horses unaffected and affected with recurrent airway obstruction.

Authors:  Sumanth Polikepahad; Masudul Haque; Joseph Francis; Rustin M Moore; Changaram S Venugopal
Journal:  Can J Vet Res       Date:  2008-07       Impact factor: 1.310

2.  Humoral control of airway tone.

Authors:  N C Thomson; K D Dagg; S G Ramsay
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

3.  The effects of calcitonin gene-related peptide on tracheal smooth muscle of guinea-pigs in vitro.

Authors:  H Ninomiya; Y Uchida; T Endo; M Ohtsuka; A Nomura; M Saotome; S Hasegawa
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

4.  Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi.

Authors:  T Fukuroda; S Ozaki; M Ihara; K Ishikawa; M Yano; T Miyauchi; S Ishikawa; M Onizuka; K Goto; M Nishikibe
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

5.  Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease.

Authors:  D J Abraham; R Vancheeswaran; M R Dashwood; V S Rajkumar; P Pantelides; S W Xu; R M du Bois; C M Black
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

6.  The distribution and density of receptor subtypes for endothelin-1 in peripheral lung of the rat, guinea-pig and pig.

Authors:  R G Goldie; A C D'Aprile; G J Self; P J Rigby; P J Henry
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

7.  Endothelin-1-induced potentiation of human airway smooth muscle proliferation: an ETA receptor-mediated phenomenon.

Authors:  R A Panettieri; R G Goldie; P J Rigby; A J Eszterhas; D W Hay
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

8.  Suc-[Glu9,Ala11,15]-endothelin-1 (8-21), IRL 1620, identifies two populations of ET(B) receptors in guinea-pig bronchus.

Authors:  M R Mazzoni; M C Breschi; F Ceccarelli; N Lazzeri; L Giusti; P Nieri; A Lucacchini
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 9.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

10.  The induction of a biphasic bronchospasm by the ETB agonist, IRL 1620, due to thromboxane A2 generation and endothelin-1 release in guinea-pigs.

Authors:  S Noguchi; Y Kashihara; C Bertrand
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.